Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

UBS
Baxter
Julphar
Merck
McKesson
US Department of Justice
Federal Trade Commission
Cantor Fitzgerald
Fuji

Generated: July 15, 2018

DrugPatentWatch Database Preview

Epinephrine bitartrate - Generic Drug Details

see a sample report or, see our see our flat-rate plans

« Back to Dashboard

What are the generic sources for epinephrine bitartrate and what is the scope of epinephrine bitartrate patent protection?

Epinephrine bitartrate
is the generic ingredient in eight branded drugs marketed by Wyeth Cons, 3M, Astrazeneca, Dentsply Pharm, Deproco, and Septodont Inc, and is included in nine NDAs. Additional information is available in the individual branded drug profile pages.

There are nineteen drug master file entries for epinephrine bitartrate.
Summary for epinephrine bitartrate
Synonyms for epinephrine bitartrate
(-)-3,4-dihydroxy-a-((methylamino)methyl)benzyl alcohol(+)-tartrate(1:1) salt
(-)-3,4-Dihydroxy-alpha-((methylamino)methyl)benzyl alcohol (+)-tartrate (1:1) salt
(-)-Adrenaline acid tartrate
(-)-Adrenaline bitartrate
(-)-Adrenaline hydrogen tartrate
(-)-Adrenaline tartrate
(-)-Epinephrine (+)-bitartrate
(-)-Epinephrine (+)-bitartrate salt, solid
(-)-Epinephrine (+)-bitartrate salt, tested according to Ph.Eur.
(-)-Epinephrine bitartrate
(2R,3R)-2,3-dihydroxybutanedioic acid; 4-[(1R)-1-hydroxy-2-(methylamino)ethyl]benzene-1,2-diol
(2R,3R)-2,3-dihydroxybutanedioic acid;4-[(1R)-1-hydroxy-2-(methylamino)ethyl]benzene-1,2-diol
(R)-(-)-Epinephrine bitartrate
(R)-4-(1-hydroxy-2-(methylamino)ethyl)benzene-1,2-diol (2R,3R)-2,3-dihydroxysuccinate
1,2-Benzenediol, 4-(1-hydroxy-2-(methylamino)ethyl)-, (R)-, (R-(R*,R*))-2,3-dihydroxybutanedioate (1:1) (salt)
1,2-Benzenediol, 4-(1-hydroxy-2-(methylamino)ethyl)-, (theta)-, (theta-(theta,theta))-2,3-dihydroxybutanedioate (1:1) (salt)
16536-89-3
24351-82-4
30Q7KI53AK
3506-10-3
4-[(1R)-1-hydroxy-2-(methylamino)ethyl]benzene-1,2-diol, (2R,3R)-2,3-dihydroxy butanedioic acid
51-42-3
5502-52-3
8028-06-6
AB1009544
AC1L1L78
AC1Q5R39
Adrenaline acid tartrate
Adrenaline acid tartrate, l-
Adrenaline bitartrate
Adrenaline hydrogen tartrate
adrenaline tartrate
Adrenaline Tartrate (L-Adrenaline Tartrate)
Adrenaline tartrate with impurity A, European Pharmacopoeia (EP) Reference Standard
Adrenaline tartrate, European Pharmacopoeia (EP) Reference Standard
Adrenaline tatrate
Adrenalinetartrate
AKOS015951390
AN-24393
Asmatane mist (TN)
Asthmahaler
BC677071
BCP0726000242
BCP9000650
Benzyl alcohol, 3,4-dihydroxy-alpha-((methylamino)methyl)-, (-)-, tartrate (1:1), (+)-
Bronitin
Bronitin Mist
Bronkaid Mist Suspension
CAS-51-42-3
CHEMBL1200818
CS-2557
D02149
DSSTox_CID_29375
DSSTox_GSID_49415
DSSTox_RID_83490
DTXSID3049415
EINECS 200-097-1
Epinephrine acid tartrate
Epinephrine bitartrate (Adrenalinium)
Epinephrine bitartrate (JAN/USP)
Epinephrine bitartrate [USAN:JAN]
Epinephrine bitartrate [USP:JAN]
Epinephrine Bitartrate, pharmaceutical secondary standard; traceable to USP, PhEur and BP
Epinephrine bitartrate, United States Pharmacopeia (USP) Reference Standard
Epinephrine d-bitartrate
Epinephrine hydrogen tartrate
EPINEPHRINE TARTRATE
epinephrinehydrogentartrate
HY-B0447A
KB-50546
L-Adrenalin Bitartrate
l-Adrenaline bitartrate
l-Adrenaline d-bitartrate
l-Adrenaline hydrogen tartrate
L-Adrenaline tartrate
L-ADRENALINEBITARTRATE
L-Epinephrine (Bitartrate)
l-Epinephrine bitartrate
l-Epinephrine d-bitartrate
l-Epinephrine tartrate
L-tartaric acid; epinephrine
L(+)-tartaric acid; epinephrine
LS-42887
Medihaler-epi (TN)
MolPort-003-910-040
NCGC00260385-01
Primatene Mist Suspension
s2521
SCHEMBL40741
ST50409530
Tox21_202839
UNII-30Q7KI53AK

US Patents and Regulatory Information for epinephrine bitartrate

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Astrazeneca DURANEST epinephrine bitartrate; etidocaine hydrochloride INJECTABLE;INJECTION 017751-007 Approved Prior to Jan 1, 1982 DISCN Yes No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Astrazeneca CITANEST FORTE epinephrine bitartrate; prilocaine hydrochloride INJECTABLE;INJECTION 014763-008 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Dentsply Pharm CITANEST FORTE DENTAL epinephrine bitartrate; prilocaine hydrochloride INJECTABLE;INJECTION 021383-001 Approved Prior to Jan 1, 1982 AP RX Yes Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
3m MEDIHALER-EPI epinephrine bitartrate AEROSOL, METERED;INHALATION 010374-003 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

see a sample report or, see our see our flat-rate plans

see a sample report or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Dow
Julphar
Cipla
Chinese Patent Office
Cantor Fitzgerald
Boehringer Ingelheim
Citi
Farmers Insurance
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.